Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James J Harding

Showing results (71-80 of 138) with videos related to

Pageof 14
Sort By:
Annals of Surgical Oncology|July 23, 2024
Has Management of Intrahepatic Cholangiocarcinoma Evolved with the Evidence? Trends and Practice Patterns from the National Cancer DatabaseLauren E Schleimer, Hannah L Kalvin, Ryan J Ellis, et al.
Cancer|August 24, 2017
A phase 1/1B trial of ADI-PEG 20 plus nab-paclitaxel and gemcitabine in patients with advanced pancreatic adenocarcinomaMaeve A Lowery, Kenneth H Yu, David Paul Kelsen, et al.
Cancer|August 28, 2019
Second-line chemotherapy in advanced biliary cancers: A retrospective, multicenter analysis of outcomesMaeve A Lowery, Laura W Goff, Bridget P Keenan, et al.
Radiology|August 12, 2020
NRF2 Dysregulation in Hepatocellular Carcinoma and Ischemia: A Cohort Study and Laboratory InvestigationEtay Ziv, Yiru Zhang, Luke Kelly, et al.
Current Oncology (Toronto, Ont.)|October 27, 2023
Safety and Efficacy of Hepatic Artery Embolization in Heavily Treated Patients with Intrahepatic Cholangiocarcinoma: Analysis of Clinicopathological and Radiographic Parameters Associated with Better Overall SurvivalSara Velayati, Ahmed Elsakka, Ken Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2018
Binimetinib plus Gemcitabine and Cisplatin Phase I/II Trial in Patients with Advanced Biliary CancersMaeve A Lowery, Mikaela Bradley, Joanne F Chou, et al.
Journal of Gastrointestinal Oncology|September 17, 2021
Ablative radiation therapy for hepatocellular carcinoma is associated with reduced treatment- and tumor-related liver failure and improved survivalLara Hilal, Marsha Reyngold, Abraham J Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2021
Phase II Clinical Trial of Everolimus in a Pan-Cancer Cohort of Patients with mTOR Pathway AlterationsElio Adib, Katarzyna Klonowska, Krinio Giannikou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 30, 2021
Blocking TIM-3 in Treatment-refractory Advanced Solid Tumors: A Phase Ia/b Study of LY3321367 with or without an Anti-PD-L1 AntibodyJames J Harding, Victor Moreno, Yung-Jue Bang, et al.
The Oncologist|June 18, 2020
Phase Ib Study of Enzalutamide with or Without Sorafenib in Patients with Advanced Hepatocellular CarcinomaJames J Harding, Robin K Kelley, Benjamin Tan, et al.
Pageof 14

Showing results (71-80 of 138) with videos related to

Sort By:
Pageof 14
Annals of Surgical Oncology|July 23, 2024
Has Management of Intrahepatic Cholangiocarcinoma Evolved with the Evidence? Trends and Practice Patterns from the National Cancer DatabaseLauren E Schleimer, Hannah L Kalvin, Ryan J Ellis, et al.
Cancer|August 24, 2017
A phase 1/1B trial of ADI-PEG 20 plus nab-paclitaxel and gemcitabine in patients with advanced pancreatic adenocarcinomaMaeve A Lowery, Kenneth H Yu, David Paul Kelsen, et al.
Cancer|August 28, 2019
Second-line chemotherapy in advanced biliary cancers: A retrospective, multicenter analysis of outcomesMaeve A Lowery, Laura W Goff, Bridget P Keenan, et al.
Radiology|August 12, 2020
NRF2 Dysregulation in Hepatocellular Carcinoma and Ischemia: A Cohort Study and Laboratory InvestigationEtay Ziv, Yiru Zhang, Luke Kelly, et al.
Current Oncology (Toronto, Ont.)|October 27, 2023
Safety and Efficacy of Hepatic Artery Embolization in Heavily Treated Patients with Intrahepatic Cholangiocarcinoma: Analysis of Clinicopathological and Radiographic Parameters Associated with Better Overall SurvivalSara Velayati, Ahmed Elsakka, Ken Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2018
Binimetinib plus Gemcitabine and Cisplatin Phase I/II Trial in Patients with Advanced Biliary CancersMaeve A Lowery, Mikaela Bradley, Joanne F Chou, et al.
Journal of Gastrointestinal Oncology|September 17, 2021
Ablative radiation therapy for hepatocellular carcinoma is associated with reduced treatment- and tumor-related liver failure and improved survivalLara Hilal, Marsha Reyngold, Abraham J Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2021
Phase II Clinical Trial of Everolimus in a Pan-Cancer Cohort of Patients with mTOR Pathway AlterationsElio Adib, Katarzyna Klonowska, Krinio Giannikou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 30, 2021
Blocking TIM-3 in Treatment-refractory Advanced Solid Tumors: A Phase Ia/b Study of LY3321367 with or without an Anti-PD-L1 AntibodyJames J Harding, Victor Moreno, Yung-Jue Bang, et al.
The Oncologist|June 18, 2020
Phase Ib Study of Enzalutamide with or Without Sorafenib in Patients with Advanced Hepatocellular CarcinomaJames J Harding, Robin K Kelley, Benjamin Tan, et al.
Pageof 14